Research News and Research

RSS

HPA-specific shRNA holds potential as a novel therapeutic strategy for gastric cancer

Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression of HPA, the traditional HPA inhibitors may produce nonspecific and undesirable effects. In recent years, genetic approaches targeting HPA have been regarded as a promising alternative.

25 Nov 2009

Data miners can inform drug companies of doctors' prescribing habits

The Baltimore Sun reports: "[P]harmaceutical companies that make … prescription drugs are also looking over the doctor's shoulder, keeping track of how many prescriptions for whose drugs the individual physician is writing."

25 Nov 2009

Novel way to fight UTIs: Research into Alzheimer's disease

Research into Alzheimer's disease seems an unlikely approach to yield a better way to fight urinary tract infections (UTIs), but that's what scientists at Washington University School of Medicine in St. Louis and elsewhere recently reported.

25 Nov 2009

Health companies' momentum may cut right through reform savings

Health companies have done better than the rest of corporate America during the past decade, MarketWatch/Seattle Times reports. While profits at the S&P 500 companies declined slightly over 10 years, "[d]ata compiled by MarketWatch show that the 52 health-care companies in the index are about to close out the decade with average profits that nearly tripled."

25 Nov 2009

7 tips on cutting medical bills

Research into medical billing has revealed that it is possible to drastically and immediately cut medical expenses not covered by medical insurance plans. www.BestHealthcareRates.com, a knowledgeable leader in the online medical insurance field, has collected the 7 best tips to help individuals pay off medical bills quicker by first reducing them to more manageable levels.

25 Nov 2009

Senate Health Committee likely to hold hearing on new mammogram guidelines

Roll Call reports that 22 senators have written the Senate Health, Education, Labor and Pensions Committee asking its leaders to hold hearings on controversial new mammogram guidelines. "The letter came less than a week after the U.S. Preventive Services Task Force recommended looser guidelines for breast cancer screenings. The task force suggested that women wait until they turn 50 to begin screening and then undergo one mammogram every two years instead of every year."

25 Nov 2009

Emerging trends that drive the U.S. market for trauma fixation devices

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the nearly $3 billion US market for trauma fixation devices will continue to see rapid growth over the next five years despite the recent economic slowdown. MRG's US Markets for Trauma Devices 2010 report finds that this market will remain highly dynamic over the next five years, with competitors introducing specialized devices in previously underserved segments of the trauma fixation market, fueling market growth.

25 Nov 2009

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

25 Nov 2009

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

‏Dr. Sarit Larisch, Head of the Cell Death Research Laboratory and senior lecturer at the University of Haifa, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

25 Nov 2009

Major direct health benefits by reducing carbon dioxide and other greenhouse emissions

Tackling climate change by reducing carbon dioxide and other greenhouse emissions will have major direct health benefits in addition to reducing the risk of climate change, especially in low-income countries, according to a series of six papers appearing today (Wed., Nov. 25) in the British journal The Lancet.

25 Nov 2009

UGR researchers provide early diagnosis of ARMD and keratitis

Researchers from the UGR have provided an early diagnosis of certain ocular diseases that are very common today, such as age-related macular degeneration and keratitis, by applying an existing optical technique that, nevertheless, had never before been used for this purpose.

25 Nov 2009

Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals

Idera Pharmaceuticals, Inc., today announced that Novartis will terminate its research collaboration agreement with the Company, effective as of February 21, 2010.

25 Nov 2009

Seven-day event focuses on nuclear medicine, molecular imaging, nanomedicine and clinical trials

SNM will hold its Conjoint Mid-Winter Meetings Jan. 27-Feb. 2, 2010, at the Albuquerque Convention Center in Albuquerque, N.M. This year, SNM joins its annual Mid-Winter Educational Symposium with the 2010 Annual Meeting and Educational Symposium of the American College of Nuclear Medicine (ACNM), the Nanomedicine and Molecular Imaging Summit and the Clinical Trials Network Community Workshop.

25 Nov 2009

FDA approves Berinert for treating HAE in adults and adolescents

Berinert®, a human C1 esterase inhibitor (C1-INH) for treating acute episodes of facial or abdominal hereditary angioedema (HAE) in adults and adolescents has obtained approval from the US Food and Drug Administration (FDA).

25 Nov 2009

Journal policies call for authors to disclose COIs for improved transparency

Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.

25 Nov 2009

IES to install electrical systems at the U.S. Army Medical Research Institute of Infectious Diseases

IES, a leading national provider of electrical and communications systems and services for the commercial, industrial and residential markets, announced today that its commercial business group has been awarded a contract from Manhattan Torcon JV to install the electrical systems for the Level 4 bio-safety lab (BSL-4) replacement facility at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick in Frederick, Md.

25 Nov 2009

GeckoSystems learns new insights during home care robot trials

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that during their first week of real world evaluation trials, for their fully autonomous personal companion home care robot, the CareBot™, they have learned some surprising and some, not surprising, insights.

25 Nov 2009

Multiple Sclerosis Society of Canada to invite research operating grant proposals related to CCSVI and MS

The Multiple Sclerosis Society of Canada announced it will request research operating grants related to chronic cerebrospinal venous insufficiency (CCSVI) and MS.

25 Nov 2009

'Suicide gene E' reduces potent drug dosage in cancer patients

Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.

25 Nov 2009

Innovotech announces financial results for third-quarter 2009

Innovotech Inc. today announced its unaudited financial and operational results for the three and nine month periods ended September 30, 2009.

25 Nov 2009

Research News and Research

HPA-specific shRNA holds potential as a novel therapeutic strategy for gastric cancer

Data miners can inform drug companies of doctors' prescribing habits

Novel way to fight UTIs: Research into Alzheimer's disease

Health companies' momentum may cut right through reform savings

7 tips on cutting medical bills

Senate Health Committee likely to hold hearing on new mammogram guidelines

Emerging trends that drive the U.S. market for trauma fixation devices

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

Major direct health benefits by reducing carbon dioxide and other greenhouse emissions

UGR researchers provide early diagnosis of ARMD and keratitis

Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals

Seven-day event focuses on nuclear medicine, molecular imaging, nanomedicine and clinical trials

FDA approves Berinert for treating HAE in adults and adolescents

Journal policies call for authors to disclose COIs for improved transparency

IES to install electrical systems at the U.S. Army Medical Research Institute of Infectious Diseases

GeckoSystems learns new insights during home care robot trials

Multiple Sclerosis Society of Canada to invite research operating grant proposals related to CCSVI and MS

'Suicide gene E' reduces potent drug dosage in cancer patients

Innovotech announces financial results for third-quarter 2009

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News